Daniel Ajabshir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Daniel Ajabshir has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Adriana Pedraza
1 shared publication- Alexandra Lazcano-Ornelas
School of Medicine, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico
1 shared publication - Angelica Gousse
Gousse Urology 21097 NE 27th Ct #200, Aventura, FL 33180, USA
1 shared publication - Angelo E. Gousse
Memorial Hospital Miramar, South Broward Hospital District
1 shared publication - Aravindh Rathinam
Desai Sethi Urology Institute, University of Miami, Miller School of Medicine, Miami, USA
1 shared publication - Archan Khandekar
Leonard M. Miller School of Medicine, University of Miami, Desai Sethi Urology Institute, Miami, USA
1 shared publication
Latest Publications
- Open Access
The Role of the Urinary and Gut Microbiome in Bladder Cancer: Emerging Insights and Clinical Implications
Bladder cancer (BCa) arises from the interaction between environmental exposures and the host’s immunity and microbiome. Once considered sterile, the urinary tract is now known to harbor a resident urinary microbiome (UM) that dynamically interacts with the immune system and is influenced by systemic immunomodulatory effects of the gut microbiome (GM) brought on by the emerging gut–bladder axis. Accumulating evidence links alterations in UM and GM leading to BCa development, progression, and recurrence. Loss of protective taxa (e.g., Lactobacillus, Bifidobacterium and Ruminococcus) and enrichment of pro-inflammatory or genotoxic bacteria (e.g., Fusobacterium, Acinetobacter, Prevotella and Enterobacteriaceae) are associated with immune evasion and systemic inflammation. Microbial metabolites, especially short-chain fatty acids (SCFAs), play a key role in shaping tumor immunity and show diagnostic and prognostic potential, with specific microbial signatures correlating with recurrence risk, survival, and treatment response. Therapeutically, growing evidence suggests that microbiome composition influences immunotherapy response, highlighting opportunities for microbiome-based interventions. This review aims to summarize the rationale to implement microbial modulation strategies (e.g., dietary modulation, probiotics, fecal microbiota transplantation (FMT), and emerging synbiotic or postbiotic approaches) while addressing their current limitations and future requirements in order to develop microbiome-guided therapies, diagnostics and prognostic tools for BCa.
Open AccessThe Role of the Urinary and Gut Microbiome in Bladder Cancer: Emerging Insights and Clinical Implications
Bladder cancer (BCa) arises from the interaction between environmental exposures and the host’s immunity and microbiome. Once considered sterile, the urinary tract is now known to harbor a resident urinary microbiome (UM) that dynamically interacts with the immune system and is influenced by systemic immunomodulatory effects of the gut microbiome (GM) brought on by the emerging gut–bladder axis. Accumulating evidence links alterations in UM and GM leading to BCa development, progression, and recurrence. Loss of protective taxa (e.g., Lactobacillus, Bifidobacterium and Ruminococcus) and enrichment of pro-inflammatory or genotoxic bacteria (e.g., Fusobacterium, Acinetobacter, Prevotella and Enterobacteriaceae) are associated with immune evasion and systemic inflammation. Microbial metabolites, especially short-chain fatty acids (SCFAs), play a key role in shaping tumor immunity and show diagnostic and prognostic potential, with specific microbial signatures correlating with recurrence risk, survival, and treatment response. Therapeutically, growing evidence suggests that microbiome composition influences immunotherapy response, highlighting opportunities for microbiome-based interventions. This review aims to summarize the rationale to implement microbial modulation strategies (e.g., dietary modulation, probiotics, fecal microbiota transplantation (FMT), and emerging synbiotic or postbiotic approaches) while addressing their current limitations and future requirements in order to develop microbiome-guided therapies, diagnostics and prognostic tools for BCa.
- 1 January 2026
- Published by Tech Science Press in Canadian Journal of Urology
- p. 1-10
The role of micro-ultrasound in active surveillance for prostate cancer
Active surveillance (AS) requires reliable imaging to detect grade progression in low-risk prostate cancer. This narrative review evaluates the role of high-resolution micro-ultrasound (micro-US) in AS and its integration with multiparametric magnetic resonance imaging (mpMRI). A targeted synthesis of randomized trials, prospective cohorts, and meta-analyses through December 2025 was performed. The OPTIMUM randomized trial demonstrated non-inferiority of micro-US–guided biopsy for detecting Grade Group 2 or higher cancer. In AS cohorts, micro-US shows high sensitivity (94–97%) and negative predictive value (88–97%) for detecting grade reclassification. These findings support its role as a real-time targeting modality and as a triage tool to reduce unnecessary biopsies, particularly in MRI-limited or discordant settings. Limitations include operator dependence, inter-reader variability, and evolving performance in anterior-zone assessment influenced by training and emerging protocols. Overall, micro-US represents a complementary modality within AS pathways, with ongoing trials expected to define its role in longitudinal surveillance.
- 1 January 2026
- Published by Tech Science Press in Canadian Journal of Urology
- p. 1-10
The role of micro-ultrasound in active surveillance for prostate cancer
Active surveillance (AS) requires reliable imaging to detect grade progression in low-risk prostate cancer. This narrative review evaluates the role of high-resolution micro-ultrasound (micro-US) in AS and its integration with multiparametric magnetic resonance imaging (mpMRI). A targeted synthesis of randomized trials, prospective cohorts, and meta-analyses through December 2025 was performed. The OPTIMUM randomized trial demonstrated non-inferiority of micro-US–guided biopsy for detecting Grade Group 2 or higher cancer. In AS cohorts, micro-US shows high sensitivity (94–97%) and negative predictive value (88–97%) for detecting grade reclassification. These findings support its role as a real-time targeting modality and as a triage tool to reduce unnecessary biopsies, particularly in MRI-limited or discordant settings. Limitations include operator dependence, inter-reader variability, and evolving performance in anterior-zone assessment influenced by training and emerging protocols. Overall, micro-US represents a complementary modality within AS pathways, with ongoing trials expected to define its role in longitudinal surveillance.
- Open Access
- 11 October 2025
- Published by Elsevier in Urology Case Reports
- Vol. 63
Recurrent idiopathic ischemic priapism in a healthy pediatric patient: A case report
- 11 October 2025
- Published by Elsevier in Urology Case Reports
- Vol. 63
Open AccessRecurrent idiopathic ischemic priapism in a healthy pediatric patient: A case report
- Open Access
- 25 June 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-8
Analyzing retraction trends in urology: a comprehensive study over the last decade
Objective: To investigate why retractions in academic literature have risen substantially, leading to rising concerns about research reliability and integrity. While retraction trends have been explored across disciplines, urology-specific factors remain underexamined. This study investigates 292 retracted urological publications from 2014 to 2024, focusing on open-access journals to analyze how publishing models influence retraction trends. Methods: A retrospective analysis of retracted urological publications was conducted using the PubMed database. The study employed 84 MeSH search terms to identify articles and categorize them by research type, journal impact factor, citation count, geographical distribution, and retraction reasons. Statistical analyses were performed to assess associations between retraction characteristics. Results: The most common reason for retraction (90.4%) was discrepancies in data availability or research description, with systematic publication manipulation accounting for 5.1%. The majority of retractions (84.5%) originated from China. Journals with higher impact factors exhibited longer recall times for retractions but no significant difference in citation count at recall. Conclusion: This study highlights the increasing frequency of retractions in urology and identifies key factors influencing these trends. Geographic disparities, open-access models, and journal impact factors play significant roles. Addressing research integrity requires improved editorial oversight, standardized reporting guidelines, and enhanced detection of publication misconduct.
- 25 June 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-8
Open AccessAnalyzing retraction trends in urology: a comprehensive study over the last decade
Objective: To investigate why retractions in academic literature have risen substantially, leading to rising concerns about research reliability and integrity. While retraction trends have been explored across disciplines, urology-specific factors remain underexamined. This study investigates 292 retracted urological publications from 2014 to 2024, focusing on open-access journals to analyze how publishing models influence retraction trends. Methods: A retrospective analysis of retracted urological publications was conducted using the PubMed database. The study employed 84 MeSH search terms to identify articles and categorize them by research type, journal impact factor, citation count, geographical distribution, and retraction reasons. Statistical analyses were performed to assess associations between retraction characteristics. Results: The most common reason for retraction (90.4%) was discrepancies in data availability or research description, with systematic publication manipulation accounting for 5.1%. The majority of retractions (84.5%) originated from China. Journals with higher impact factors exhibited longer recall times for retractions but no significant difference in citation count at recall. Conclusion: This study highlights the increasing frequency of retractions in urology and identifies key factors influencing these trends. Geographic disparities, open-access models, and journal impact factors play significant roles. Addressing research integrity requires improved editorial oversight, standardized reporting guidelines, and enhanced detection of publication misconduct.
- Open Access
- 12 February 2025
- Published by MDPI AG in Société Internationale d’Urologie Journal
- Vol. 6 (1) , 12
Review on the Management of Female Urinary Incontinence and Anterior Vaginal Prolapse
Objectives: We aimed to evaluate management strategies for female urinary incontinence, specifically stress urinary incontinence (SUI), and anterior vaginal prolapse (pelvic organ prolapse, POP), emphasizing diagnostic methods, treatment options, and factors influencing surgical outcomes. Methods: We conducted a thorough literature review examining diagnostic tools, including physical examinations, urodynamic testing, and pessary evaluations, alongside treatment options for SUI and POP. Both surgical interventions, such as mid-urethral sling placement and anterior colporrhaphy, and non-surgical methods, including pelvic floor exercises, were analyzed. This review assesses these approaches’ efficacy, complications, and outcomes, incorporating current clinical guidelines and evidence-based practices. Results: Evidence indicates that SUI frequently coexists with POP, with a notable proportion of cases being occult until a prolapse is reduced. Diagnostic methods such as pessary testing and urodynamic evaluations are essential in identifying masked SUI, though their predictive accuracy varies. Surgical techniques such as using mid-urethral slings are highly effective but pose risks, including voiding dysfunction and lower urinary tract injury. Long-term data emphasize the need for personalized treatment strategies, with combined procedures showing superior outcomes for the concurrent management of POP and SUI in select cases. Conclusions: Effective management of SUI and POP requires a personalized approach, factoring in the severity of a prolapse and the likelihood of postoperative incontinence. While conservative treatments are practical initial options, surgical solutions, such as mid-urethral slings and apical suspension procedures, offer robust, lasting results for advanced cases. Preoperative diagnostics, collaborative decision-making, and tailored treatment plans are essential to optimize success and minimize complications. Future research should prioritize enhancing diagnostic precision and refining surgical methods to further advance patient care.
- 12 February 2025
- Published by MDPI AG in Société Internationale d’Urologie Journal
- Vol. 6 (1) , 12
Open AccessReview on the Management of Female Urinary Incontinence and Anterior Vaginal Prolapse
Objectives: We aimed to evaluate management strategies for female urinary incontinence, specifically stress urinary incontinence (SUI), and anterior vaginal prolapse (pelvic organ prolapse, POP), emphasizing diagnostic methods, treatment options, and factors influencing surgical outcomes. Methods: We conducted a thorough literature review examining diagnostic tools, including physical examinations, urodynamic testing, and pessary evaluations, alongside treatment options for SUI and POP. Both surgical interventions, such as mid-urethral sling placement and anterior colporrhaphy, and non-surgical methods, including pelvic floor exercises, were analyzed. This review assesses these approaches’ efficacy, complications, and outcomes, incorporating current clinical guidelines and evidence-based practices. Results: Evidence indicates that SUI frequently coexists with POP, with a notable proportion of cases being occult until a prolapse is reduced. Diagnostic methods such as pessary testing and urodynamic evaluations are essential in identifying masked SUI, though their predictive accuracy varies. Surgical techniques such as using mid-urethral slings are highly effective but pose risks, including voiding dysfunction and lower urinary tract injury. Long-term data emphasize the need for personalized treatment strategies, with combined procedures showing superior outcomes for the concurrent management of POP and SUI in select cases. Conclusions: Effective management of SUI and POP requires a personalized approach, factoring in the severity of a prolapse and the likelihood of postoperative incontinence. While conservative treatments are practical initial options, surgical solutions, such as mid-urethral slings and apical suspension procedures, offer robust, lasting results for advanced cases. Preoperative diagnostics, collaborative decision-making, and tailored treatment plans are essential to optimize success and minimize complications. Future research should prioritize enhancing diagnostic precision and refining surgical methods to further advance patient care.